These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 11453313

  • 1. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH, Hem E, Stensrud T, Held T, Herland K, Mowinckel P.
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [Abstract] [Full Text] [Related]

  • 2. The effect of formoterol inhalation on endurance performance in hypobaric conditions.
    Riiser A, Tjørhom A, Carlsen KH.
    Med Sci Sports Exerc; 2006 Dec; 38(12):2132-7. PubMed ID: 17146320
    [Abstract] [Full Text] [Related]

  • 3. Effects of formoterol on endurance performance in athletes at an ambient temperature of -20 degrees C.
    Tjørhom A, Riiser A, Carlsen KH.
    Scand J Med Sci Sports; 2007 Dec; 17(6):628-35. PubMed ID: 17316372
    [Abstract] [Full Text] [Related]

  • 4. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W.
    Sports Med; 2007 Dec; 37(2):95-102. PubMed ID: 17241101
    [Abstract] [Full Text] [Related]

  • 5. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I, Hall IP, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [Abstract] [Full Text] [Related]

  • 6. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma.
    Hermansen MN, Nielsen KG, Buchvald F, Jespersen JJ, Bengtsson T, Bisgaard H.
    Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010
    [Abstract] [Full Text] [Related]

  • 7. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
    Goldkorn A, Diotto P, Burgess C, Weatherall M, Holt S, Beasley R, Siebers R.
    Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
    [Abstract] [Full Text] [Related]

  • 8. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B, Wuestenfeld JC, Kindermann W.
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [Abstract] [Full Text] [Related]

  • 9. The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes.
    Carlsen KH, Ingjer F, Kirkegaard H, Thyness B.
    Scand J Med Sci Sports; 1997 Jun; 7(3):160-5. PubMed ID: 9200320
    [Abstract] [Full Text] [Related]

  • 10. The use of inhaled formoterol in the treatment of asthma.
    Berger WE.
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [Abstract] [Full Text] [Related]

  • 11. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.
    van Baak MA, de Hon OM, Hartgens F, Kuipers H.
    Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835
    [Abstract] [Full Text] [Related]

  • 12. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma.
    Ferrari M, Balestreri F, Baratieri S, Biasin C, Oldani V, Lo Cascio V.
    Respiration; 2000 Oct; 67(5):510-3. PubMed ID: 11070454
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 14. Effect of cold exposure (-15 degrees C) and salbutamol treatment on physical performance in elite nonasthmatic cross-country skiers.
    Sandsund M, Sue-Chu M, Helgerud J, Reinertsen RE, Bjermer L.
    Eur J Appl Physiol Occup Physiol; 1998 Mar; 77(4):297-304. PubMed ID: 9562357
    [Abstract] [Full Text] [Related]

  • 15. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W, Meyer T.
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [Abstract] [Full Text] [Related]

  • 16. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U, Viktrup L, Davidsen O, Viskum K.
    Ugeskr Laeger; 1992 Nov 16; 154(47):3325-8. PubMed ID: 1361083
    [Abstract] [Full Text] [Related]

  • 17. Formoterol provides long-lasting protection against exercise-induced bronchospasm.
    Bronsky EA, Yegen U, Yeh CM, Larsen LV, Della Cioppa G.
    Ann Allergy Asthma Immunol; 2002 Oct 16; 89(4):407-12. PubMed ID: 12392386
    [Abstract] [Full Text] [Related]

  • 18. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
    Ekström T, Ringdal N, Tukiainen P, Runnerström E, Soliman S.
    Ann Allergy Asthma Immunol; 1998 Sep 16; 81(3):225-30. PubMed ID: 9759798
    [Abstract] [Full Text] [Related]

  • 19. Salmeterol and physical performance at -15 degrees C in highly trained nonasthmatic cross-country skiers.
    Sue-Chu M, Sandsund M, Helgerud J, Reinertsen RE, Bjermer L.
    Scand J Med Sci Sports; 1999 Feb 16; 9(1):48-52. PubMed ID: 9974197
    [Abstract] [Full Text] [Related]

  • 20. Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD.
    Derom E, Strandgården K, Schelfhout V, Borgström L, Pauwels R.
    Respir Med; 2007 Sep 16; 101(9):1931-41. PubMed ID: 17544264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.